Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
What's in a Number? Examining the Prognostic and Predictive Importance of Platelet Count in Patients With Essential ThrombocythemiaAndrew T Kuykendall, Rami Komrokji
Current Hematologic Malignancy Reports|November 29, 2019
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARROAndrew T Kuykendall, Eric Padron
Journal of Immunotherapy and Precision Oncology|June 6, 2022
JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with MyelofibrosisAndrew T Kuykendall, Rami S Komrokji
Blood and Lymphatic Cancer : Targets and Therapy|October 1, 2025
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor TherapiesSamuel B Reynolds, Rami Komrokji, Andrew T Kuykendall
Blood Cancer Journal|January 27, 2022
JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activationGarima Pandey, Andrew T Kuykendall, Gary W Reuther
Expert Opinion on Emerging Drugs|June 18, 2021
Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia veraFranco Castillo Tokumori, Rami Komrokji, Andrew T Kuykendall
Clinical Lymphoma, Myeloma & Leukemia|May 15, 2024
Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and PhysiciansAndrew T Kuykendall, Jennifer T Fine, Marina Kremyanskaya
Veterinary and Comparative Orthopaedics and Traumatology : V.C.O.T|January 31, 2015
Complete sequencing and characterization of equine aggrecanE H G Caporali, T Kuykendall, M C Stewart
Hematology/Oncology Clinics of North America|March 1, 2021
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap SyndromesAndrew T Kuykendall, Franco Castillo Tokumori, Rami S Komrokji
Pageof 6